NCT05002010

Brief Summary

Assess the prevalence and features of left ventricular hypertrophy in patients with chronic kidney disease (CKD) taking into account gender differences and stage of CKD. To detect factors those predict LVH in CKD. \*to assess the right ventricle dysfunction in CKD .

Trial Health

35
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
200

participants targeted

Target at P75+ for all trials

Timeline
Completed

Started Feb 2022

Shorter than P25 for all trials

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

July 24, 2021

Completed
19 days until next milestone

First Posted

Study publicly available on registry

August 12, 2021

Completed
6 months until next milestone

Study Start

First participant enrolled

February 1, 2022

Completed
9 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

November 1, 2022

Completed
1 month until next milestone

Study Completion

Last participant's last visit for all outcomes

December 1, 2022

Completed
Last Updated

February 22, 2022

Status Verified

February 1, 2022

Enrollment Period

9 months

First QC Date

July 24, 2021

Last Update Submit

February 18, 2022

Conditions

Outcome Measures

Primary Outcomes (1)

  • Detecting the prevalence of LVH in CKD.

    The types of LVH in different stages of CKD. Risk factors of LVH in different stages of CKD

    through study completion, an average of 1 year".

Secondary Outcomes (1)

  • The types of LVH in different stages of CKD. Risk factors of LVH in different stages of CKD

    through study completion, an average of 1 year".

Interventions

EchoDEVICE

Measure the Left ventricle (LV): IVS (interventricular septum), LVEDD(left ventricle end diastolic dimension ),LVESD((left ventricle end systolic dimension ), PWD(posterior wall dimension), LV systolic dysfunction and LV diastolic dysfunction.

Eligibility Criteria

Age16 Years - 65 Years
Sexall
Healthy VolunteersNo
Age GroupsChild (0-17), Adult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

Assess the prevalence and features of left ventricular hypertrophy in patients with chronic kidney disease (CKD) taking into account gender differences and stage of CKD.

You may qualify if:

  • \- Patients with chronic renal disease (CKD) aged between 16 and 65 years will be included.
  • CKD are diagnosed based on criteria proposed by KDIGO (Kidney Disease: Improving Global Outcomes) in 2002

You may not qualify if:

  • Patients with structural heart disease (congenital or valvular heart disease). Patients with primary hypertension. Patients with obstructive or restrictive lung disease.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Related Publications (1)

  • Vallianou NG, Mitesh S, Gkogkou A, Geladari E. Chronic Kidney Disease and Cardiovascular Disease: Is there Any Relationship? Curr Cardiol Rev. 2019;15(1):55-63. doi: 10.2174/1573403X14666180711124825.

    PMID: 29992892BACKGROUND

MeSH Terms

Conditions

Hypertrophy, Left VentricularRenal Insufficiency, Chronic

Condition Hierarchy (Ancestors)

CardiomegalyHeart DiseasesCardiovascular DiseasesHypertrophyPathological Conditions, AnatomicalPathological Conditions, Signs and SymptomsRenal InsufficiencyKidney DiseasesUrologic DiseasesFemale Urogenital DiseasesFemale Urogenital Diseases and Pregnancy ComplicationsUrogenital DiseasesMale Urogenital DiseasesChronic DiseaseDisease AttributesPathologic Processes

Central Study Contacts

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
CROSS SECTIONAL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Official title resident Doctor

Study Record Dates

First Submitted

July 24, 2021

First Posted

August 12, 2021

Study Start

February 1, 2022

Primary Completion

November 1, 2022

Study Completion

December 1, 2022

Last Updated

February 22, 2022

Record last verified: 2022-02